초록 ▼

This invention relates to novel chemically-modified nucleic acid molecules having specific formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel c

This invention relates to novel chemically-modified nucleic acid molecules having specific formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel chemically modified nucleic acid molecules, and compositions and cells comprising said molecules.

대표청구항 ▼

1. A nucleic acid molecule having the formula XIII: iB-rprprprprprprpDsDsDsDsDsDsDsDsDsrprprprprprpr-iB wherein each r is independently a 2'-O-alkyl nucleotide, each D is independently a deoxyribonucleotide or 2'-arabinofluoro nucleotide, each s is independently a phosphorothioate, phosphorodithioa

1. A nucleic acid molecule having the formula XIII: iB-rprprprprprprpDsDsDsDsDsDsDsDsDsrprprprprprpr-iB wherein each r is independently a 2'-O-alkyl nucleotide, each D is independently a deoxyribonucleotide or 2'-arabinofluoro nucleotide, each s is independently a phosphorothioate, phosphorodithioate, 5'-thiophosphate, 3'-thiophosphate, or methylphosphonate internucleotide linkage, each p is independently a phosphodiester internucleotide linkage, and each iB is independently an inverted abasic moiety. 2. The nucleic acid molecule of claim 1, wherein said 2'-O-alkyl nucleotide is a 2'-O-methyl nucleotide. 3. The nucleic acid molecule of claim 1, wherein said 2'-O-alkyl nucleotide is a 2'-O-allyl nucleotide. 4. The nucleic acid molecule of claim 1, wherein said inverted abasic moiety is a 3',3'-linked or 5',5'-linked deoxyabasic moiety. 5. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule is an antisense nucleic acid molecule. 6. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule further comprises a 2-5A antisense chimera. 7. A method of modulating the expression of a gene in a cell in culture comprising the step of administering to said cell a nucleic acid molecule of claim 1 under conditions suitable for the down regulation of said gene. 8. A mammalian cell in culture including a nucleic acid molecule of claim 1. 9. The mammalian cell of claim 8, wherein said mammalian cell is a human cell. 10. A composition comprising the nucleic acid molecule of claim 1 and a pharmaceutically acceptable carrier. 11. A method of administering to a cell in culture a nucleic acid molecule of claim 1 comprising contacting said cell with the nucleic acid molecule under conditions suitable for said administration. 12. The method of claim 11, wherein said cell is a mammalian cell. 13. The method of claim 11, wherein said cell is a human cell. 14. The method of claim 11, wherein said administration is in the presence of a delivery reagent. 15. The method of claim 14, wherein said delivery reagent is a lipid. 16. The method of claim 15, wherein said lipid is a cationic lipid. 17. The method of claim 14, wherein said delivery reagent is a liposome.